CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome: Moreover, advances in liquid biopsy techniques may allow non-invasive detection of CDH1 mutations and monitoring of treatment response in LBC patients, offering a valuable tool for personalized management [10].